🔎 Trials Near Me

Home › Malattie polmonari › Florida

Studi clinici su Malattie polmonari nello stato di Florida

26 studi su Malattie polmonari cercano partecipanti presso sedi nello stato di Florida.

Città nello stato di Florida

Testo ufficiale dello studio (inglese)

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Sylvester Comprehensive Cancer Center Miami, Miami
  • AdventHealth Cancer Institute, Orlando
  • H Lee Moffitt Cancer Center and Research Institute, Tampa
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06765109

A Study of COVID-19 Vaccine(s) in Children and Adults

  • C & R Research Servcies USA, Inc., Homestead
  • Indago Research & Health Center, Inc, Miami Lakes
In reclutamentoFase 3Volontari sani benvenuti
Età 5 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07798648

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • BRP- Hialeah Hospital, Hialeah
  • D&H Cancer Research Center LLC, Margate
  • Kendall South Medical Center, Miami
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07013474

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Millennium Medical Research - Miami, Miami
  • Deluxe Health Center, Miami Lakes
  • Florida Institute For Clinical Research, LLC, Orlando
In reclutamentoFase 2
Età da 40 a 75 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07759245

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Innovative Research of West Florida, Clearwater
  • Invictus Clinical Research Group, Coconut Creek
  • Hillcrest Medical Research LLC, DeLand
  • e altri 16
In reclutamentoFase 3
Età 12 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06679140

American Lung Association (ALA) Lung Health Cohort

  • Nemours Children's Jacksonville, Jacksonville
  • University of Florida, Jacksonville, Jacksonville
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 25 a 35 · Tutti i sessi · Aggiornato il 23 set 2026 · NCT04543461

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Florida Cancer Specialists, Sarasota
  • Moffitt Cancer Center and Research Institute, Tampa
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06128551

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

  • Site 1009, Plantation
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07407933

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Gainesville
  • GSK Investigational Site, Naples
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06572384

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Millennium Oncology Research Clinic, Hollywood
  • University of Florida - Jacksonville, Jacksonville
  • Miami Cancer Institute at Baptist Health, Inc., Miami
  • e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06119581

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • University of Florida, Jacksonville
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07059091

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Kissimmee
In reclutamentoFase 2
Età da 18 a 85 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07333183

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Gainesville
  • Research Site, Jacksonville
  • Research Site, Lakeland
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT05624450

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

  • Research Site, Miami
  • Research Site, Pembroke Pines
  • Research Site, Saint Cloud
In reclutamentoFase 2
Età da 4 a 11 · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT07525375

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

  • GC2501 Study Site 103, Gainesville
  • GC2501 Study Site 105, Miami
In reclutamentoFase 3
Età da 18 a 80 · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT07555483

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age

  • Palm Springs Community Health Center, Miami Lakes
In reclutamentoFase 4Volontari sani benvenuti
Età da 18 a 64 · Tutti i sessi · Aggiornato il 7 ago 2026 · NCT07730450

Deep Functional Phenotyping of the ALA Lung Health Cohort

  • Nemours Children's Jacksonville, Jacksonville
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 25 a 35 · Tutti i sessi · Aggiornato il 17 lug 2026 · NCT06177717

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • H Lee Moffitt Cancer Center and Research Institute, Tampa
In reclutamentoFase 2
Età da 18 a 70 · Tutti i sessi · Aggiornato il 26 giu 2026 · NCT04614103

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

  • Sylvester Comprehensive Cancer Center, Miami
  • Orlando Health Cancer Institute, Orlando
  • Moffitt Cancer Center, Tampa
In reclutamentoFase 1/2
Età da 18 a 70 · Tutti i sessi · Aggiornato il 11 giu 2026 · NCT05361174

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Memorial Healthcare System, Hollywood
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 27 mag 2026 · NCT03093116

Data Collection Using Eko Digital Devices in a Clinical Setting

  • Nemours Children's Health, Jacksonville
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 26 mag 2026 · NCT07227376

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients

  • University of Miami, Miami
In reclutamentoStudio osservazionale
Età da 18 a 75 · Tutti i sessi · Aggiornato il 23 mar 2026 · NCT06494033

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • Bay Pines VA Healthcare System, Pay Pines, FL, Bay Pines
  • Miami VA Healthcare System, Miami, FL, Miami
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 feb 2026 · NCT02984761

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • AdventHealth Orlando, Orlando
  • Moffitt Cancer Center, Tampa
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 dic 2025 · NCT06619561

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • Florida Lung Asthma and Sleep Specialist, Celebration
  • Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 12 nov 2025 · NCT05975983

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

  • University of Florida, Jacksonville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 lug 2024 · NCT02735707

Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.